The validity of a hyperventilation test for an investigation of autonomic failure: Assessment in patients with multiple system atrophy and Parkinson's disease

International Journal of Clinical Practice

Volumn 60, Issue 12, 2006, Pages 1542-1547

  Deguchi, K ^a   Sasaki, I ^a   Ikeda, K ^a   Shimamura, M ^a   Urai, Y ^a   Tsukaguchi, M ^a   Touge, T ^a   Takeuchi, H ^a   Kuriyama, S ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Autonomic nervous system; Blood pressure; Heart rate; Hyperventilation; Hypocarbia; Multiple system atrophy; Orthostatic hypotension

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR SYMPTOM; CONTROLLED STUDY; FUNCTION TEST; HEAD POSITION; HEART RATE; HUMAN; HYPERVENTILATION; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; SHY DRAGER SYNDROME; VALIDITY; VALSALVA MANEUVER;

ADULT; AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; HEART RATE; HUMANS; HYPERVENTILATION; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; TILT-TABLE TEST;

EID: 33751002035     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00802.x     Document Type: Article

References (19)

1. Alexopoulos D, Christodoulou J, Toulgaridis T et al. Hemodynamic response to hyperventilation test in healthy volunteers. Clin Cardiol 1995; 18: 636-41.
2. Burnum JF, Hickam JB, McIntosh HD. The effect of hypocapnia on arterial blood pressure. Circulation 1954; 9: 89-95.
3. Fontana F, Bernardi P, Pich EM et al. Opioid peptide modulation of circulatory response to hyperventilation in humans. Peptides 2000; 21: 1223-30.
4. Todd GPA, Chadwick IG, Yeo WW et al. Pressor effect of hyperventilation in healthy subjects. J Hum Hypertens 1995; 9: 119-22.
5. Onrot J, Bernard GR, Biaggioni I et al. Direct vasodilator effect of hyperventilation-induced hypocarbia in autonomic failure patients. Am J Med Sci 1991; 301: 305-9.
6. Van de Borne P, Mezzetti S, Montano N et al. Hyperventilation alters arterial baroreflex control of heart rate and muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol 2000; 279: H536-41.
7. Mathias CJ, Bannister R. Investigation of autonomic disorders. In: Mathias CJ, Bannister R, eds. Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. New York: Oxford University Press, 1999: 169-95.
8. Fontana F, Bernardi P, Spampinato S et al. β-Endorphin modulation of pressor response to hyperventilation in hypertensive patients. Peptides 2002; 23: 911-8.
9. Gilman S, Low PA, Quinn N et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999; 163: 94-8.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.
11. Deguchi K, Sasaki I, Touge T et al. Abnormal baroreceptor-mediated vasopressin release as possible marker in early diagnosis of multiple system atrophy. J Neurol Neurosurg Psychiatry 2004; 75: 110-5.
12. Bouhaddi M, Vuillier F, Fortrat JO et al. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: Involvement of L-dopa therapy. Auton Neurosci 2004; 116: 30-8.
13. Fleckenstein A, Nakayama K, Fleckenstein-Grun B, Byon YK. Interaction of hydrogen ions, calcium-antagonistic drugs and cardiac glycosides with excitation-contraction coupling of vascular smooth muscle. In: Betz E, ed. Ionic Action on Vascular Smooth Muscle. Berlin: Springer-Verlag, 1976: 117-25.
14. Sundram P, Reddy HK, McElroy PA et al. Myocardial energetics and efficiency in patients with idiopathic cardiomyopathy: Response to dobutamine and amrinone. Am Heart J 1990; 119: 891-8.
15. Heizmann CW, Braun K. Changes in Ca (2+)-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992; 15: 259-64.
16. Ito H, Kusaka H, Matsumoto S, Imai T. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy. Neurology 1996; 47: 1291-9.
17. Polinsky RJ, Brown RT, Lee GK et al. Beta-endorphin, ACTH, and catecholamine responses in chronic autonomic failure. Ann Neurol 1987; 21: 573-7.
18. Ishibashi T, Kubota K, Himeno M et al. Respiratory alkalosis does not alter NOx concentrations in human plasma and erythrocytes. Am J Physiol Heart Circ Physiol 2001; 281: H2757-61.
19. Strauss GI, Edvinsson L, Larsen FS et al. Circulating levels of neuropeptides (CGRP, VIP, NPY) in patients with fulminant hepatic failure. Neuropeptides 2001; 35: 174-80.